氨基甲酰-PAF(C16)结构式
|
常用名 | 氨基甲酰-PAF(C16) | 英文名 | 1-O-HEXADECYL-2-N-METHYLCARBAMYL-SN-GLYCERO-3-PHOSPHOCHOLINE |
---|---|---|---|---|
CAS号 | 91575-58-5 | 分子量 | 538.698 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C26H55N2O7P | 熔点 | N/A | |
MSDS | 美版 | 闪点 | N/A |
氨基甲酰-PAF(C16)用途Methylcarbamyl PAF C-16 is a stable analog of PAF C-16 with a half-life greater than 100 minutes in platelet poor plasma due to its resistance to degradation by PAF-AH. |
中文名 | 氨基甲酰-PAF(C16) |
---|---|
英文名 | [(2R)-3-hexadecoxy-2-(methylcarbamoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate |
英文别名 | 更多 |
分子式 | C26H55N2O7P |
---|---|
分子量 | 538.698 |
精确质量 | 538.374695 |
PSA | 115.96000 |
LogP | 3.92 |
储存条件 | -20°C冷藏、密闭、干燥处 |
稳定性 | 按规定使用和贮存的不会分解,避氧化物 |
计算化学 | 1.疏水参数计算参考值(XlogP):6.3 2.氢键供体数量:1 3.氢键受体数量:7 4.可旋转化学键数量:26 5.互变异构体数量:2 6.拓扑分子极性表面积106 7.重原子数量:36 8.表面电荷:0 9.复杂度:565 10.同位素原子数量:0 11.确定原子立构中心数量:1 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
更多 | 1. 性状:白色粉末 2. 密度(g/mL25 ºC):未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):未确定 5. 沸点(ºC,常压):未确定 6. 沸点(ºC0.8mmHg):未确定 7. 折射率:未确定 8. 闪点(ºC):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):未确定 11. 蒸气压(kPa,):未确定 12. 饱和蒸气压(kPa,60ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(正辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:H2O: 20 mg/mL |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
J. Clin. Invest. 115(10) , 2855-61, (2005) Staphylococcus aureus infections are known triggers for skin inflammation and can modulate immune responses. The present studies used model systems consisting of platelet-activating factor receptor-po... |
|
Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes.
J. Invest. Dermatol. 107(1) , 88-94, (1996) Platelet-activating factor (PAF) is a potent inflammatory mediator that is thought to play a role in cutaneous inflammation. These studies used mass spectrometry to examine the molecular species of PA... |
|
The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells.
J. Biol. Chem. 281(42) , 31495-501, (2006) Chlamydia trachomatis has evolved a profound anti-apoptotic activity that may aid in chlamydial evasion of host defense. The C. trachomatis anti-apoptotic activity has been correlated with blockade of... |
MFCD00065891 |
Ethanaminium, 2-[[[(2R)-3-(hexadecyloxy)-2-[[(methylamino)carbonyl]oxy]propoxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt |
Methylcarbamol |
mc-PAF |
mcPlatelet activating factor |
(2R)-3-(Hexadecyloxy)-2-[(methylcarbamoyl)oxy]propyl 2-(trimethylammonio)ethyl phosphate |
cPAF |